Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors

A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has been shown that unlike the biaryl analogs, th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2009-01, Vol.19 (1), p.264-274
Hauptverfasser: Chirapu, Srinivas Reddy, Pachaiyappan, Boobalan, Nural, Hikmet F., Cheng, Xin, Yuan, Hongbin, Lankin, David C., Abdul-Hay, Samer O., Thatcher, Gregory R.J., Shen, Yong, Kozikowski, Alan P., Petukhov, Pavel A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 274
container_issue 1
container_start_page 264
container_title Bioorganic & medicinal chemistry letters
container_volume 19
creator Chirapu, Srinivas Reddy
Pachaiyappan, Boobalan
Nural, Hikmet F.
Cheng, Xin
Yuan, Hongbin
Lankin, David C.
Abdul-Hay, Samer O.
Thatcher, Gregory R.J.
Shen, Yong
Kozikowski, Alan P.
Petukhov, Pavel A.
description A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has been shown that unlike the biaryl analogs, the fused-ring moiety is successfully accommodated in the BACE1 binding site resulting in the ligands with excellent inhibitory activity. Ligand 5b reduced 65% of Aβ40 production in N2a cells stably transfected with Swedish human APP.
doi_str_mv 10.1016/j.bmcl.2008.10.096
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2643073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X08012870</els_id><sourcerecordid>66769385</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-6a47c022171ac6c49efc4d4049c97a3c22bc0a2ac76accd5a208360477126cb43</originalsourceid><addsrcrecordid>eNqNkU2LFDEYhIMo7rj6BzxILnraHt98THoaZGEd1g9Y8aLgLaTfTu9kSCdr0j0w_960M6x6UU-BylOVCkXIcwZLBky93i3bAf2SA6yLsIRGPSALJpWshITVQ7IoClTrRn47I09y3gEwCVI-JmesASbqhi8Ifore4uRNokPsrHfh9oLmQxi3Nrt8QU3oqMHR7d14oHmcOmczjT0NcW89bZ1JB_8T6qdsuyoVP317tblm1IWta90YU35KHvXGZ_vsdJ6Tr--uv2w-VDef33_cXN1UuJKrsVJG1gics5oZVCgb26PsSuMGm9oI5LxFMNxgrQxitzIc1kKBrGvGFbZSnJPLY-7d1A62QxvGZLy-S24oNXU0Tv95E9xW38a95koKqEUJeHUKSPH7ZPOoB5fRem-CjVPWStWqEevVP0EOQhaS_QdY3uZyBvkRxBRzTra_r81Az2vrnZ7X1vPas1a2LaYXv3_4l-U0bwFengCT0fg-mYAu33OcgZjJwr05crbMs3c26YzOBrSdSxZH3UX3tx4_AFRnyUs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20264241</pqid></control><display><type>article</type><title>Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chirapu, Srinivas Reddy ; Pachaiyappan, Boobalan ; Nural, Hikmet F. ; Cheng, Xin ; Yuan, Hongbin ; Lankin, David C. ; Abdul-Hay, Samer O. ; Thatcher, Gregory R.J. ; Shen, Yong ; Kozikowski, Alan P. ; Petukhov, Pavel A.</creator><creatorcontrib>Chirapu, Srinivas Reddy ; Pachaiyappan, Boobalan ; Nural, Hikmet F. ; Cheng, Xin ; Yuan, Hongbin ; Lankin, David C. ; Abdul-Hay, Samer O. ; Thatcher, Gregory R.J. ; Shen, Yong ; Kozikowski, Alan P. ; Petukhov, Pavel A.</creatorcontrib><description>A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has been shown that unlike the biaryl analogs, the fused-ring moiety is successfully accommodated in the BACE1 binding site resulting in the ligands with excellent inhibitory activity. Ligand 5b reduced 65% of Aβ40 production in N2a cells stably transfected with Swedish human APP.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2008.10.096</identifier><identifier>PMID: 19013792</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Alzheimer ; Amyloid beta-Peptides - antagonists &amp; inhibitors ; Amyloid beta-Peptides - biosynthesis ; Amyloid beta-Protein Precursor - genetics ; Amyloid Precursor Protein Secretases - antagonists &amp; inhibitors ; Aspartic Acid Endopeptidases - antagonists &amp; inhibitors ; Aspartic protease ; BACE1 ; Binding Sites ; Biological and medical sciences ; Cell Line ; Computer Simulation ; Computer-aided molecular design ; Drug Design ; Humans ; Ligands ; Medical sciences ; Models, Molecular ; Neuropharmacology ; Pharmacology. Drug treatments ; Protease Inhibitors - chemical synthesis ; Protease Inhibitors - pharmacology ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Transfection</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2009-01, Vol.19 (1), p.264-274</ispartof><rights>2008 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-6a47c022171ac6c49efc4d4049c97a3c22bc0a2ac76accd5a208360477126cb43</citedby><cites>FETCH-LOGICAL-c545t-6a47c022171ac6c49efc4d4049c97a3c22bc0a2ac76accd5a208360477126cb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2008.10.096$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21030137$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19013792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chirapu, Srinivas Reddy</creatorcontrib><creatorcontrib>Pachaiyappan, Boobalan</creatorcontrib><creatorcontrib>Nural, Hikmet F.</creatorcontrib><creatorcontrib>Cheng, Xin</creatorcontrib><creatorcontrib>Yuan, Hongbin</creatorcontrib><creatorcontrib>Lankin, David C.</creatorcontrib><creatorcontrib>Abdul-Hay, Samer O.</creatorcontrib><creatorcontrib>Thatcher, Gregory R.J.</creatorcontrib><creatorcontrib>Shen, Yong</creatorcontrib><creatorcontrib>Kozikowski, Alan P.</creatorcontrib><creatorcontrib>Petukhov, Pavel A.</creatorcontrib><title>Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has been shown that unlike the biaryl analogs, the fused-ring moiety is successfully accommodated in the BACE1 binding site resulting in the ligands with excellent inhibitory activity. Ligand 5b reduced 65% of Aβ40 production in N2a cells stably transfected with Swedish human APP.</description><subject>Alzheimer</subject><subject>Amyloid beta-Peptides - antagonists &amp; inhibitors</subject><subject>Amyloid beta-Peptides - biosynthesis</subject><subject>Amyloid beta-Protein Precursor - genetics</subject><subject>Amyloid Precursor Protein Secretases - antagonists &amp; inhibitors</subject><subject>Aspartic Acid Endopeptidases - antagonists &amp; inhibitors</subject><subject>Aspartic protease</subject><subject>BACE1</subject><subject>Binding Sites</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Computer Simulation</subject><subject>Computer-aided molecular design</subject><subject>Drug Design</subject><subject>Humans</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Protease Inhibitors - chemical synthesis</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Transfection</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU2LFDEYhIMo7rj6BzxILnraHt98THoaZGEd1g9Y8aLgLaTfTu9kSCdr0j0w_960M6x6UU-BylOVCkXIcwZLBky93i3bAf2SA6yLsIRGPSALJpWshITVQ7IoClTrRn47I09y3gEwCVI-JmesASbqhi8Ifore4uRNokPsrHfh9oLmQxi3Nrt8QU3oqMHR7d14oHmcOmczjT0NcW89bZ1JB_8T6qdsuyoVP317tblm1IWta90YU35KHvXGZ_vsdJ6Tr--uv2w-VDef33_cXN1UuJKrsVJG1gics5oZVCgb26PsSuMGm9oI5LxFMNxgrQxitzIc1kKBrGvGFbZSnJPLY-7d1A62QxvGZLy-S24oNXU0Tv95E9xW38a95koKqEUJeHUKSPH7ZPOoB5fRem-CjVPWStWqEevVP0EOQhaS_QdY3uZyBvkRxBRzTra_r81Az2vrnZ7X1vPas1a2LaYXv3_4l-U0bwFengCT0fg-mYAu33OcgZjJwr05crbMs3c26YzOBrSdSxZH3UX3tx4_AFRnyUs</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Chirapu, Srinivas Reddy</creator><creator>Pachaiyappan, Boobalan</creator><creator>Nural, Hikmet F.</creator><creator>Cheng, Xin</creator><creator>Yuan, Hongbin</creator><creator>Lankin, David C.</creator><creator>Abdul-Hay, Samer O.</creator><creator>Thatcher, Gregory R.J.</creator><creator>Shen, Yong</creator><creator>Kozikowski, Alan P.</creator><creator>Petukhov, Pavel A.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090101</creationdate><title>Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors</title><author>Chirapu, Srinivas Reddy ; Pachaiyappan, Boobalan ; Nural, Hikmet F. ; Cheng, Xin ; Yuan, Hongbin ; Lankin, David C. ; Abdul-Hay, Samer O. ; Thatcher, Gregory R.J. ; Shen, Yong ; Kozikowski, Alan P. ; Petukhov, Pavel A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-6a47c022171ac6c49efc4d4049c97a3c22bc0a2ac76accd5a208360477126cb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Alzheimer</topic><topic>Amyloid beta-Peptides - antagonists &amp; inhibitors</topic><topic>Amyloid beta-Peptides - biosynthesis</topic><topic>Amyloid beta-Protein Precursor - genetics</topic><topic>Amyloid Precursor Protein Secretases - antagonists &amp; inhibitors</topic><topic>Aspartic Acid Endopeptidases - antagonists &amp; inhibitors</topic><topic>Aspartic protease</topic><topic>BACE1</topic><topic>Binding Sites</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Computer Simulation</topic><topic>Computer-aided molecular design</topic><topic>Drug Design</topic><topic>Humans</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Protease Inhibitors - chemical synthesis</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chirapu, Srinivas Reddy</creatorcontrib><creatorcontrib>Pachaiyappan, Boobalan</creatorcontrib><creatorcontrib>Nural, Hikmet F.</creatorcontrib><creatorcontrib>Cheng, Xin</creatorcontrib><creatorcontrib>Yuan, Hongbin</creatorcontrib><creatorcontrib>Lankin, David C.</creatorcontrib><creatorcontrib>Abdul-Hay, Samer O.</creatorcontrib><creatorcontrib>Thatcher, Gregory R.J.</creatorcontrib><creatorcontrib>Shen, Yong</creatorcontrib><creatorcontrib>Kozikowski, Alan P.</creatorcontrib><creatorcontrib>Petukhov, Pavel A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chirapu, Srinivas Reddy</au><au>Pachaiyappan, Boobalan</au><au>Nural, Hikmet F.</au><au>Cheng, Xin</au><au>Yuan, Hongbin</au><au>Lankin, David C.</au><au>Abdul-Hay, Samer O.</au><au>Thatcher, Gregory R.J.</au><au>Shen, Yong</au><au>Kozikowski, Alan P.</au><au>Petukhov, Pavel A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>19</volume><issue>1</issue><spage>264</spage><epage>274</epage><pages>264-274</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A series of transition state analogues of beta-secretases 1 and 2 (BACE1, 2) inhibitors containing fused-ring or biaryl moieties were designed computationally to probe the S2 pocket, synthesized, and tested for BACE1 and BACE2 inhibitory activity. It has been shown that unlike the biaryl analogs, the fused-ring moiety is successfully accommodated in the BACE1 binding site resulting in the ligands with excellent inhibitory activity. Ligand 5b reduced 65% of Aβ40 production in N2a cells stably transfected with Swedish human APP.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>19013792</pmid><doi>10.1016/j.bmcl.2008.10.096</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (1), p.264-274
issn 0960-894X
1464-3405
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2643073
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Alzheimer
Amyloid beta-Peptides - antagonists & inhibitors
Amyloid beta-Peptides - biosynthesis
Amyloid beta-Protein Precursor - genetics
Amyloid Precursor Protein Secretases - antagonists & inhibitors
Aspartic Acid Endopeptidases - antagonists & inhibitors
Aspartic protease
BACE1
Binding Sites
Biological and medical sciences
Cell Line
Computer Simulation
Computer-aided molecular design
Drug Design
Humans
Ligands
Medical sciences
Models, Molecular
Neuropharmacology
Pharmacology. Drug treatments
Protease Inhibitors - chemical synthesis
Protease Inhibitors - pharmacology
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Transfection
title Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A25%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20modeling,%20synthesis,%20and%20activity%20studies%20of%20novel%20biaryl%20and%20fused-ring%20BACE1%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Chirapu,%20Srinivas%20Reddy&rft.date=2009-01-01&rft.volume=19&rft.issue=1&rft.spage=264&rft.epage=274&rft.pages=264-274&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2008.10.096&rft_dat=%3Cproquest_pubme%3E66769385%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20264241&rft_id=info:pmid/19013792&rft_els_id=S0960894X08012870&rfr_iscdi=true